EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Impact of Hydroxychloroquine on Primary Feto-Placental Endothelial Cells from Healthy and Early-Onset Preeclamptic Placentas

Maja Gajić iD, Bianca Schröder-Heurich iD, Monika Horvat Mercnik, Mila Cervar-Zivkovic, Christian Wadsack iD, Frauke von Versen-Höynck iD, Karoline Mayer-Pickel iD

International Journal of Molecular Sciences · 30.06.2023 · 24 (13) · 10934

DOI: 10.3390/ijms241310934 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 30.06.2023. Verfasst von Maja Gajić und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Medical University of Graz, Auenbruggerplatz 14, A-8036 Graz, Austria. Hauptthemen laut MEDLINE: Placenta, Pre-Eclampsia. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Austrian Science Fund FWF, Austrian Science Fund (FWF), the Medical University of Graz.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hydroxychloroquine (HCQ), an anti-malarial drug, is suggested as a promising candidate for the treatment of pregnancy-related disorders associated with endothelial activation, among which there is preeclampsia (PE). Arterial feto-placental endothelial cells (fpECAs) were isolated from control (CTR) and early-onset preeclamptic (EO-PE) placentas. The aim of this study was to test potential protective effects of HCQ in an in vitro model of endothelial activation as well as in cells isolated from EO-PE placentas. To mimic PE conditions, CTR fpECAs were exposed to a pro-inflammatory environment consisting of tumor necrosis factor α (TNF-α), interleukin (IL)-6 and IL-1β (furtherly referred as MIX) with or without varying concentrations of HCQ (1 µg/mL and 10 µg/mL). Their effect on wound healing and endothelial barrier integrity was analyzed. Variations in the expression of IL-8 and leukocyte adhesion molecules (LAM) on both mRNA and protein levels were determined between CTR and PE fpECAs in the presence or absence of HCQ. MIX decreased wound healing and stability of the endothelial barrier, but HCQ did not affect it. Significant differences between CTR and EO-PE fpECAs were observed in IL-8 mRNA, protein secretion, and vascular cell adhesion protein 1 (VCAM-1) mRNA expression levels. After challenging CTR fpECAs with MIX, upregulation of both mRNA and protein levels was observed in all molecules. Combined treatment of HCQ and MIX slightly lowered VCAM-1 total protein amount. In CTR fpECAs, treatment with low concentrations of HCQ alone (1 µg/mL) reduced basal levels of IL-8 and VCAM-1 mRNA and secretion of IL-8, while in EO-PE fpECAs, a higher (10µg/mL) HCQ concentration slightly reduced the gene expression of IL-8. Conclusion: These results provide additional support for the safety of HCQ, as it did not adversely affect endothelial functionality in control fpECAs at the tested concentration. Furthermore, the observed limited effects on IL-8 secretion in EO-PE fpECAs warrant further investigation, highlighting the need for clinical trials to assess the potential therapeutic effects of HCQ in preeclampsia. Conducting clinical trials would offer a more comprehensive understanding of HCQ’s efficacy and safety, allowing us to explore its potential benefits and limitations in a real-world clinical setting.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PlacentaPre-EclampsiaPregnancyFemaleHumansHydroxychloroquineEndothelial CellsVascular Cell Adhesion Molecule-1Interleukin-8Interleukin-6RNA, Messenger

Stichwörter der Autor:innen

IL-8VCAM-1endothelial cellshydroxychloroquine (HCQ)preeclampsia (PE)

Substanzen

HydroxychloroquineVascular Cell Adhesion Molecule-1Interleukin-8Interleukin-6RNA, Messenger

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Medical University of Graz, Auenbruggerplatz 14, A-8036 Graz, Austria.
  • Gynecology Research Unit, Hannover Medical School, Carl-Neuberg-Strasse 1, D-30625 Hannover, Germany.
  • BioTechMed-Graz, Mozartgasse 12/II, A-8010 Graz, Austria.
  • Department of Obstetrics and Gynecology, Hannover Medical School, Carl-Neuberg-Strasse 1, D-30625 Hannover, Germany.

ORCID-Profile: Maja Gajić, Bianca Schröder-Heurich, Christian Wadsack, Frauke von Versen-Höynck, Karoline Mayer-Pickel

Förderung

  • Austrian Science Fund FWF
  • Austrian Science Fund (FWF)
  • the Medical University of Graz

Zitieren

APA

Gajić, M., Schröder-Heurich, B., Horvat Mercnik, M., Cervar-Zivkovic, M., Wadsack, C., von Versen-Höynck, F., & Mayer-Pickel, K. (2023). The Impact of Hydroxychloroquine on Primary Feto-Placental Endothelial Cells from Healthy and Early-Onset Preeclamptic Placentas. International Journal of Molecular Sciences, 24(13), 10934. https://doi.org/10.3390/ijms241310934

Vancouver

Gajić M, Schröder-Heurich B, Horvat Mercnik M, Cervar-Zivkovic M, Wadsack C, von Versen-Höynck F, et al. The Impact of Hydroxychloroquine on Primary Feto-Placental Endothelial Cells from Healthy and Early-Onset Preeclamptic Placentas. International Journal of Molecular Sciences. 2023;24(13):10934. doi:10.3390/ijms241310934

BibTeX
@article{Gaji2023,
  author = {Gajić, Maja and Schröder-Heurich, Bianca and Horvat Mercnik, Monika and Cervar-Zivkovic, Mila and Wadsack, Christian and von Versen-Höynck, Frauke and Mayer-Pickel, Karoline},
  title = {The Impact of Hydroxychloroquine on Primary Feto-Placental Endothelial Cells from Healthy and Early-Onset Preeclamptic Placentas},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {13},
  pages = {10934},
  doi = {10.3390/ijms241310934}
}
Kostenlos starten →